行TACE治疗后原发性肝细胞癌患者预后的影响因素

谭骅; 仁虹; 赵玲; 游顶云; 杨亚琛

行TACE治疗后原发性肝细胞癌患者预后的影响因素

1. 昆明医科大学第三附属医院云南省肿瘤医院介入科
2. 昆明医科大学基础医学院
3. 昆明医科大学公共卫生学院

基金项目:

基金：国家自然科学基金资助项目 (81660545);

计量
- 文章访问数: 2748
- HTML全文浏览量: 1020
- PDF下载量: 58
- 被引次数: 0
出版历程
- 收稿日期: 2018-11-15

Prognostic Factors of Patients with Primary Hepatocellular Carcinoma Treated with TACE

Funds:

基金：国家自然科学基金资助项目 (81660545);

摘要

摘要: 目的探讨行TACE术后的原发性肝细胞癌患者预后的影响因素。方法回顾性分析2006年3月至2009年10月于云南省肿瘤医院介入医学科就诊的108例原发性肝细胞癌 (HCC) 患者临床资料, 通过建立Cox回归模型, 探究各因素对行TACE治疗的HCC患者预后的影响。结果 Cox回归模型显示, TACE次数对HCC患者的生存情况影响的P值为0.007<0.05, 具有统计学差异, 行多次TACE术者的生存风险为行单次TACE术者的0.465倍;癌灶分布于肝左右叶P值为0.016, 生存风险较单分布于肝左或肝右叶高;NLR>3.97者P值约为0.05。结论 TACE次数、癌灶分布情况、NLR对行TACE治疗HCC患者的生存情况有显著影响。
- 肝细胞癌 /
- TACE治疗 /
- 预后 /
- Cox回归模型
Abstract: Objective To investigate the prognostic factors of primary hepatocellular carcinoma (HCC after TACE1. Methods The clinical data of 108 patients with primary hepatocellular carcinoma (HCC) from March 2006 to October 2009 in the Department of Interventional Medicine of Yunnan Cancer Hospital were analyzed retrospectively. The Cox regression model was established to explore the influence of various factors on the prognosis of HCC patients treated with TACE. Results The Cox regression model showed that the number of TACE had a significant effect on the survival of HCC patients (P < 0.05) , and the survival risk of the patients undergoing multiple TACE operations was significantly lower than that of the control group. P value of whose cancer located in the whole liver was 0.016, and the survival risk was higher than those distributed only in one liver lobe. P value of NLR> 3.97 was 0.050. Conclusion The number of TACE and the distribution of cancer foci have significant effect on the survival of HCC patients treated with TACE.
- Hepatocellular carcinoma /
- TACE /
- Prognosis /
- Cox regression model

HTML全文

参考文献(15)

[1]	[1]ELSERAG HB AND RUDOLPH KL. Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J].Gastroenterology, 2007, 132 (7) :2557-2576
[2]	[2]RAOUL J L, SANGRO B, FORNER A, et al. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma:available evidence and expert opinion on the use of transarterial chemoembolization[J].Cancer Treat Rev, 2011, 37 (3) :212-231.
[3]	[3]LLOVET JM, BRUIX J. Systematic review of randomized trials for unresectable hepatocellular carcinoma:chemoembolization improves survival[J]. Hepatology, 2003, 37 (2) :429-442.
[4]	[4]BURREL M, REIG M, FORNER A, et al. Survival of patients with hepatocellular carcinoma treated by transarterialchemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design[J]. J Hepatol, 2012, 56 (6) :1330-1335.
[5]	[5]SALEM R, LEWANDOWSKI R J, MULCAHY M F, et al.Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres:a comprehensive report of long-term outcomes[J]. Gastroenterology, 2010, 138 (1) :52-64.
[6]	[6]FARAZI P A, DEPINHO R A. Hepatocellular carcinoma pathogenesis:from genes to environment[J]. Nature Reviews Cancer, 2006, 6 (9) :674-687.
[7]	[7]BRUIX J, RAOUL J-L, SHERMAN M, et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma:subanalyses of a phase III trial[J]. J Hepatol, 2012, 57 (4) :821-829.
[8]	[8]MALAGARI K, CHATZIMICHAEL K, ALEXOPOULOU E, et al. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads:results of an open-label study of 62 patients[J]. Cardiovasc Intervent Radiol, 2008, 31 (2) :269-280.
[9]	[9]LLOVET J M, REAL M I, MONTA A X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:a randomised controlled trial[J]. The Lancet, 2002, 359 (9319) :1734-1739.
[10]袁维国.肝细胞肝癌肝切除术前TACE对预后影响的Meta分析[J].中国肿瘤外科杂志, 2010, 02 (5) :282-287.
[11]杨可立, 陈锦滨, 朱应钦, 等.炎症预后评分与肝癌射频消融术预后的相关性[J].广东医学, 2018, 39 (15) :2294-2299.
[12]张劲夫, 范正军, 梁润威, 等.术前SIRI和PLR对肝癌切除术后病人生存预测价值分析[J].中国实用外科杂志, 2018, 38 (2) :210-218.
[13]何朝滨, 林小军.中性粒细胞/淋巴细胞比值血小板/淋巴细胞比值与TACE治疗肝癌患者预后的相关性[J].中国肿瘤临床, 2017, 44 (6) :283-288.
[14]郑游冰, 赵炜, 刘冰, 等.中性粒细胞-淋巴细胞比值预测肝细胞癌患者TACE术后预后[J].中国介入影像与治疗学, 2013, 10 (9) :523-526.
[15]张溪.影响BCLC C期肝细胞肝癌患者行TACE治疗预后因素的分析[D].上海:复旦大学, 2013.

相关文章(20)

[1]	张瑞婷, 阎斌, 李祖燕, 孙金敏, 姚锦. 诱导化疗时外周血原始细胞清除时间和初诊时白蛋白水平与急性髓系白血病患者基因突变及预后之间的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240817
[2]	刘春艳, 常炳庆, 李超, 任欣, 刘小琴. T淋巴细胞亚群与急性髓系白血病病理特征的关系及预测化疗预后的价值分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240518
[3]	聂琪, 刘莉, 田玥, 毛晓燕, 郭渠莲, 田新. 儿童急性B淋巴细胞白血病ACTH异常临床特征与预后分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241012
[4]	赵丽珠, 董莹, 邓玥, 杨丽华. 基于单细胞测序技术分析上皮细胞相关基因与卵巢癌患者预后的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240402
[5]	陈怡璇, 王琳, 夏秀宏, 彭在坤, 丁奕, 史润娇, 雷学芬. 自噬在肝细胞癌中的作用机制研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230416
[6]	唐杰夫, 杨德兴, 刘圣哲, 王强, 付凯, 王振方, 栾英, 李敏, 刘荣. 奥密克戎变异株老年重症感染者细胞免疫指标对预后的价值研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231214
[7]	蔡丽, 杨华英, 程建红, 曹佳, 魏娜. 小儿消化性溃疡治疗期间血清6-Keto-PGF1α、TGF-α、TXB2水平变化及对预后的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230928
[8]	张明, 于成龙, 曹锦鹏. ZNF384调控GCLM对肝细胞癌转移的机制研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231108
[9]	蒋亚萍, 杨宏英, 汪昊涵, 宁显灵, 杨谢兰. 不同肠道手术方式对肠道受侵上皮性卵巢癌患者预后的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230109
[10]	陆小华, 袁洪新. BTLA、CTLA-4基因多态性与肝癌TACE联合靶向治疗疗效及预后相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230927
[11]	张天红, 杨红菊. 外泌体miRNA在肝细胞癌中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220221
[12]	陈红兰, 吴怡, 胡滔, 王玉明. 外周血G6PD活性检测对于感染高危型人乳头瘤病毒宫颈癌患者的诊断预后价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220203
[13]	付海艳, 闫俊芳, 李红娟, 王霖, 张洁, 周宇君, 徐斌, 罗煜. 时间间隔对肝动脉化疗栓塞术序贯微波消融治疗肝细胞癌的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221127
[14]	曹凡, 刘阳文, 魏雷, 谢楠, 杨裔坚, 钱程, 李春满, 付必莽, 胥江品, 阎容稷, 曾汪. 乙型肝炎病毒与肝细胞癌微血管侵犯的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210331
[15]	吴昊昊, 杨君素, 黄保岗, 管绍勇, 郑岩, 范惠娟. 左乙拉西坦注射液治疗惊厥性癫痫持续状态的疗效及预后, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211031
[16]	田波彦, 杨勤玲, 张胶琼, 韩娜, 刘少华. 辅助性肝动脉化疗栓塞治疗肝细胞癌微血管浸润的疗效, 昆明医科大学学报.
[17]	雷喜锋, 侯峰强, 刘韬, 张伟. FOXP2抑制人肝细胞癌增殖及其机制, 昆明医科大学学报.
[18]	雷喜锋, 侯峰强, 杨少华, 张伟. miR-373在人肝细胞癌中的表达及其作用, 昆明医科大学学报.
[19]	张爱灵. 常规分割与大分割三维适形放射治疗非小细胞肺癌合并上腔静脉压迫综合征, 昆明医科大学学报.
[20]	李崇阳. 青少年骨肉瘤治疗及预后相关因素分析, 昆明医科大学学报.